The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
ketoconazole market growth driven by product launches and rising demand
The ketoconazole market, valued at $106.24 million in 2022, is projected to grow at a CAGR of 3.1% through 2030, driven by rising demand for skin care drugs and increased product launches. The oral ketoconazole segment is expected to see significant growth, particularly in the APAC region, due to a busy lifestyle and a growing population. Major players include Mylan Inc., Johnson & Johnson, and Teva Pharmaceutical Industries.